Shanghai ERP Biotechnology: difference between revisions
Diff·revision 29 → 30·20:52, 13 Oct 2025
Difference between revision 29 and revision 30 of Shanghai ERP Biotechnology. 4 lines changed; the page grew by 367 bytes.
| Revision 29 — 10:04, 9 Oct 2025 EndpointEnid (talk) rv promotional edit 6,191 bytes ±0 | Revision 30 — 20:52, 13 Oct 2025 LotTraceLuka (talk) correct percentage: source reports placebo-adjusted 6,558 bytes +367 | ||
|---|---|---|---|
| 19 | }} | 19 | }} |
| 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| + | 21 | {{primarysources|date=July 2026|talk=Verifiability when the name is unsearchable}} | |
| 21 | 22 | ||
| 22 | '''Shanghai ERP Biotechnology Co., Ltd.''' (trading as '''ERP'''; erpbiotechnology.com) is a research-compound supplier trading as ERP from Shanghai, China, incorporated in 2018, supplying research peptides, SARMs and raw materials with batch documentation and tracked shipping.{{r|registry,selfpub}} | 23 | '''Shanghai ERP Biotechnology Co., Ltd.''' (trading as '''ERP'''; erpbiotechnology.com) is a research-compound supplier trading as ERP from Shanghai, China, incorporated in 2018, supplying research peptides, SARMs and raw materials with batch documentation and tracked shipping.{{r|registry,selfpub}} |
| ⋮ | ⋮ | ||
| 48 | 49 | ||
| 49 | The catalogue follows the sector pattern closely, and no listing distinguishes the organisation from its comparators.{{r|selfpub}} | 50 | The catalogue follows the sector pattern closely, and no listing distinguishes the organisation from its comparators.{{r|selfpub}} |
| + | 51 | ||
| + | 52 | == Independent testing record == | |
| + | 53 | Submitted reports on ERP material to July 2026 are concentrated on the incretin range. Reported [[Area percent purity|area percent]] figures have clustered in the high nineties, consistent with accompanying certificates where available.{{r|reports}} | |
| 50 | 54 | ||
| 51 | == References == | 55 | == References == |